#3395

Hyuntae Kim

50 years old Self-Made

Overview

Source of Wealth
Biotech
Residence
Incheon
Education
Seoul National University (Bachelor of Business Administration)
Seoul National University (Master of Business Administration)
Marital Status
Married

Assets

  • Voronoi
    6,285,000 shares @ -
    -
    310210-KR

Biography

Hyuntae Kim is CEO of South Korean biotechnology company Voronoi.

Voronoi's two most promising cancer drug candidates are VRN10 and VRN11. Both started Phase 1 clinical trials in 2025.

Voronoi was founded by Kim's younger brother, Hyun-seok, in 2015. The older Kim took over the company in 2016 and listed it on Korea's Kosdaq in 2022.

Previously, Kim did stints as head of asset management at eBest Investment & Securities, Hanwha Investment & Securities and KB Securities.